A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/1997
12/03/1997	EP0809502A1 Method of lessening the risk of non-vertebral bone fractures
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	CN1166316A Combination therapy to treat osteoporosis
12/03/1997	CN1036588C Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
12/02/1997	US5693818 Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693674 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
12/02/1997	US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
11/1997
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044329A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/27/1997	WO1997044315A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/27/1997	WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	WO1997044051A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
11/27/1997	WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997	WO1997044023A1 Pharmaceutical compositions based on diclofenac
11/27/1997	CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	CA2253342A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/26/1997	EP0808832A2 Fluorinated vitamin D3 analogs
11/26/1997	EP0686037A4 Hormone replacement therapy
11/26/1997	CN1165665A Medicinal compsn. for treatment of spur and its prepn.
11/26/1997	CN1165654A Combination therapy to treat osteoporosis-polyphosphonates or progesting and extrogen agonists
11/25/1997	US5691340 Benzopyran derivatives
11/25/1997	US5691336 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997043235A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	CA2255589A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807121A1 New pharmaceuticals for modulating hormone responsiveness
11/19/1997	EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997	EP0806953A2 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates
11/19/1997	EP0806945A1 Therapeutic preparation for inhalation containing parathyro d hormone, pth
11/19/1997	EP0679157B1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
11/19/1997	CN1165002A 骨痹康胶囊及其制作方法 Gubi Kang Capsule and its production method
11/18/1997	US5688960 Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
11/18/1997	US5688938 Calcium receptor-active molecules
11/18/1997	US5688796 Heterocyclic substituted benzothiophenes, compositions, and methods
11/18/1997	US5688760 Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences
11/13/1997	WO1997042337A1 Gene expression in monocytes and macrophages
11/13/1997	WO1997042184A1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen fumarate
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041851A1 Benzothiophenes, formulations containing same, and methods
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	DE19619036A1 Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with carbo- or heterocyclic substituent at C-25, process for their preparation and the use thereof for producing medicaments
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253858A1 Benzothiophenes, formulations containing same, and methods
11/13/1997	CA2253322A1 Gene expression in monocytes and macrophages
11/13/1997	CA2253284A1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-¬2-(pyrrolidin-1-yl)ethoxy\|-phenyl}chromane, hyrogen fumarate
11/12/1997	EP0806420A1 Benzothiophenes, formulations containing same, and methods
11/12/1997	CN1164390A Amino acid metal chelate and its preparation and preparing method
11/11/1997	US5686485 Physiologically active EI-1941 compounds
11/11/1997	US5686471 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/11/1997	US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997	US5686421 Hydantoin derivates
11/11/1997	CA2023430C Salts of optically active 4-hydroxy-8- (3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5- triazines and a process for production thereof
11/06/1997	WO1997041129A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
11/06/1997	WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041096A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
11/06/1997	WO1997041090A1 Inorganic ion receptor-active compounds
11/06/1997	CA2253288A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents
11/06/1997	CA2252696A1 Azetidinone derivatives for the treatment of atherosclerosis
11/05/1997	EP0804469A1 Novel peptide
11/05/1997	EP0804465A1 Novel elastase inhibitors
11/05/1997	EP0804202A1 Estrogens and parathyroid hormone for treating osteoporosis
11/05/1997	EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997	EP0804180A1 Method of inhibiting cathepsin k
11/05/1997	CN1164192A Multicatalytic protease inhibitors
11/05/1997	CN1163780A Osteogenesis stimulin injection and its preparing process
11/04/1997	US5684151 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/04/1997	US5684041 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/04/1997	US5684033 Antiarthritic agents, analgesics and migraine
11/04/1997	US5684031 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/1997
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040068A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	WO1997040031A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
10/30/1997	WO1997040017A2 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997040006A2 Phosphate mimics
10/30/1997	WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
10/30/1997	WO1997039767A1 Methods for inducing bone formation
10/30/1997	WO1997039755A1 Oral pharmaceutical preparation containing ibandronat
10/30/1997	WO1997039748A1 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	CA2252778A1 Phosphate mimics
10/30/1997	CA2251808A1 Methods for inducing bone formation
10/30/1997	CA2251680A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/29/1997	EP0802908A1 Novel compounds
10/29/1997	EP0802902A1 Indole derivatives useful in the treatment of osteoporosis
10/29/1997	EP0802897A1 Novel compounds
10/29/1997	CN1163141A External application medicine for curing rheumatic and rheumatoid arthritis

1 ... 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 ... 820